|Bid||133.21 x 800|
|Ask||133.20 x 900|
|Day's Range||133.02 - 135.01|
|52 Week Range||106.11 - 149.43|
|Beta (3Y Monthly)||1.31|
|PE Ratio (TTM)||769.54|
|Earnings Date||Jul 24, 2019 - Jul 29, 2019|
|Forward Dividend & Yield||1.56 (1.28%)|
|1y Target Est||141.15|
Weak prices for generics, potential opioid liability, and rumbles of change coming from Washington pose challenges. But the market reaction has been overdone.
Change Healthcare, an independent health care technology platform, announced terms for its proposed initial public offering Friday. The IPO Terms The Nashville, Tennessee-based company plans to offer ...
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons. Nevertheless, the data show elite investors' consensus picks have done well on average over the long-term. The top 20 stocks among hedge funds beat the S&P […]
McKesson Corp NYSE:MCKView full report here! Summary * Perception of the company's creditworthiness is positive * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for MCK with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MCK. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold MCK had net inflows of $6.32 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | PositiveThe current level displays a positive indicator. MCK credit default swap spreads are near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
That's four big daily wins in a row for stocks, with the S&P 500's gain of 1.05% on Friday. It's still too soon to call it the beginning of a recovery move; it's almost too much, too fast. But, it buys time for the bulls to regroup.Source: Allan Ajifo via Wikimedia (Modified)Microsoft (NASDAQ:MSFT) carried more than its fair share of the weight, rallying 2.8% to cross back above the $1 trillion market cap mark. Weighing the market down was the 1.26% tumble from Bank of America (NYSE:BAC), setting the tone that adversely impacted most other banking names. Concerns of interest rate cuts rattled bank investors, as lower interest rates threaten bank profits. * 7 A-Rated Stocks to Buy Under $10 Neither are especially compelling trading prospects headed into this week's trading action though. Rather, take a look at stock charts of McKesson (NYSE:MCK), Coca-Cola (NYSE:KO) and CenterPoint Energy (NYSE:CNP). Here's why, and what needs to happen next.InvestorPlace - Stock Market News, Stock Advice & Trading Tips CenterPoint Energy (CNP)When we last looked at CenterPoint Energy back on May 15, it had just pushed up and off of its 200-day moving average line, only to run into resistance again. While it could have gone either way at the time, the bears actually had the edge.Since then, the 200-day line failed to keep the stock propped up. Sure, CNP snapped back in early June to cross back above the very same 200-day moving average line. With the shape and placement of Friday's bar, however, it appears CenterPoint shares are back en route to even lower lows. Click to Enlarge * The red flag is Friday's engulfing pattern, meaning the high open and low close completely engulfed Thursday's low/high range. Such a sweeping change of heart is telling. * Simultaneously, the big bearish swing also dragged CNP back below the pivotal 200-day line, plotted in white on both stock charts. * If the selling gets traction, the next likely landing spot is just under $27, where CNP found support for the better part of last year. Coca-Cola (KO)With nothing more than a quick glance, Coca-Cola looks enticing. Shares have been rallying quite well since February's low, seemingly unstoppable. The fact that a long-term resistance line, plotted in white on the weekly chart, was hurdled last week only bolsters the bullish argument.A closer, more thorough look at the weekly chart, however, reveals the advance just bumped into another rather well-established ceiling. Meanwhile, the shape of Friday's bar also suggests we're ready to pivot back into a pullback. * 10 Stocks to Buy That Could Be Takeover Targets Click to Enlarge * Friday's high aligns with the prior two major peaks from KO stock, plotted in red on the weekly chart that's also on the verge of an overbought RSI indicator. * In the daily timeframe, the open and close both near the low of a relatively tall bar, which also suggests a move from a net-buying to a net-selling environment. * While the stage is set, the move won't be complete until we get a confirmation in the form of a lower close. McKesson (MCK)Finally, given its multi-year history, doubting McKesson is on the mend now wouldn't be a tough conclusion to make. And, that may well be the case here despite a couple of bullish curiosities. Nevertheless, those curiosities are worth pointing out, as a recovery effort from here could lead into a major rally effort. Click to Enlarge * Most noteworthy is also the least noticed … not only are we now seeing a bullish MACD convergence, the most recent MACD crossover took place above the prior one. It points to a longer-term advance that needs multiple efforts to get going. * At the same time, notice on the daily chart that all the key moving average lines are about to converge after last year's divergence. The big clue to watch for is the purple 50-day average crossing above the white 200-day line. That's a "golden cross" that suggests more bullishness ahead. * The ultimate ceiling, however, is currently at $135. That's the line that connects all the major peaks since September, marked in yellow on both stock charts.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Stocks to Buy As They Hit 52-Week Lows * 4 Antitrust Tech Stocks to Keep an Eye On * 5 Gold and Silver Stocks Touching Intraday Highs Compare Brokers The post 3 Big Stock Charts for Monday: CenterPoint Energy, McKesson and Coca-Cola appeared first on InvestorPlace.
McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Having led the growth of a small health IT startup into Ohio's first billion-dollar tech acquisition, Matt Scantland is departing CoverMyMeds to foster more Central Ohio entrepreneurs and organizations.
As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with technology among them. Nevertheless, most investors decided to stick to their bullish theses and recouped their losses by the end of the first quarter. […]
Today we'll look at McKesson Corporation (NYSE:MCK) and reflect on its potential as an investment. To be precise...
An introduction to health care companies that are tops in their fields. From health care provider to pharmaceuticals, these companies have the largest global presence according to market capitalization. Learn who these health care giants are and why they may be a good investment.
The Bay Area Council emphasized the positives about Bay Area living, but almost half of survey respondents still said they may leave the region.
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of McKesson Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
The founder and chairman of Charles Schwab said he's "not sure" whether the company's headquarters will remain in San Francisco.
McKesson Corp provides medicines, pharmaceutical supplies, information and care management products and services across the healthcare industry. It operates with two segments namely McKesson Distribution Solutions and McKesson Technology Solutions. The dividend yield of McKesson Corp stocks is 1.20%.
The bank has almost every line of business in the Bay Area, including wealth management as well as lending to small and mid-sized companies and real estate investors.
IRVING, Texas-- -- Fourth-quarter fiscal 2019 revenues of $52.4 billion and full-year fiscal 2019 revenues of $214.3 billion, a full-year increase of 3%. Fourth-quarter GAAP loss per diluted share from continuing operations of $ and full-year GAAP earnings per diluted share from continuing operations of $0.17. Fourth-quarter Adjusted Earnings per diluted share of $3.69, up 6% from a year ago. Full-year ...
The company also said it had renewed a distribution agreement with its largest client, CVS Health Inc, through 2023. "McKesson reported mixed end to its FY19, but in this environment that is likely to be enough especially as guidance met expectations," an Evercore ISI note said. The mid-point of the company's 2020 adjusted profit outlook of between $13.85 and $14.45 per share was a cent above the average analyst estimate, according to IBES data from Refinitiv.